The Role of Adipose Derived Mesenchymal Stem Cells (MSCs) to Control Autoimmune Disease

Article Preview

Abstract:

There are 80 types of autoimmune diseases (ADs) with some of the same symptoms, but causes are still unclear. The major treatment of ADs is immunosuppressive drugs but these are not effective and associated with substantial toxicities. Stem cell has demonstrated remarkable effectiveness in halting destructive immune response and restoring the body to level of normal function by providing cellular level repair of damage, increasing blood flow, and reducing inflammation. Adipose tissue is one of the most potent and concentrated source of mesenchymal stem cells (MSCs) as an anti-inflammatory and tissue protecting agent which is promote healing and minimal invasive. This study conducted in 20 patients with ADs (11 women and 9 men) in various age between 22 to 70 years old. Patients treated with autologous adipose-derived MSCs implantation through catheterization. The laboratory analysis result of patients before and after MSCs application in 6 months were measured, include haemoglobin (Hb), leukocytes, erythrocyte sedimentation rate (ESR), protein and blood levels in urine, high sensitivity c-reactive protein (hsCRP), C3 and C4 complement, anti-nuclear antibodies (ANA) and anti-double stranded DNA (anti-dsDNA). MSCs are able to improve the performance of hemoglobin which statistically significant increased (p=0.002). MSCs are able to reduce the inflammatory as shown in the number of leukocytes (p=0.015) and ESR (p=0.031) which statistically significant decreased. MSCs can repair the renal function as shown in no presences of protein and blood in patient’s urine. MSCs are also able to augment the immune response as shown in hsCRP which statistically significant decreased (p<0.001), while C3 and C4 complements statistically significant increased (p<0.001). ANA and anti-dsDNA showed a negative result which means MSCs therapy may give a good response to heal the ADs.

You might also be interested in these eBooks

Info:

Pages:

89-97

Citation:

Online since:

November 2018

Export:

Price:

* - Corresponding Author

[1] Davidson A, Diamond B. 2001. Autoimmune Diseases. N Engl J Med, 345: 340-350.

Google Scholar

[2] Ming Li, Susumu Ikehara. 2013. Autoimmune Disease Treatment with Stem Cell Transplantation. J Genet Syndr Gene Ther, 4(8).

Google Scholar

[3] Progress in Autoimmune Diseases Research, Report to Congress, National Institutes of Health, The Autoimmune Diseases Coordinating Committee, March (2005).

Google Scholar

[4] Friska Jifanti, Alwi Mappiasse. 2010. Studi Retrospektif Lupus Eritematosus di Subdivisi Alergi Imunologi Bagian Ilmu Kesehatan Kulit dan Kelamin RSUP dr. Wahidin Sudirohusodo Makassar Periode 2005-2010. 2 Majalah Kesehatan PharmaMedika, 2(2).

DOI: 10.25077/jka.v7i0.873

Google Scholar

[5] Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MH. 2014. Non-pharmacological Interventions for preventing Job Loss in Workers with Inflammatory Arthritis. The Cochrane Database of Systematic Reviews.

DOI: 10.1002/14651858.cd010208.pub2

Google Scholar

[6] Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. 2009. Epidemiology and Clinical Characteristics of Behçet's Disease in The US: A Population-Based Study. Arthritis Rheum 15; 61(5): 600-4.

DOI: 10.1002/art.24423

Google Scholar

[7] DeLisa Fairweather, Sylvia Frisancho-Kiss, Noel R. Rose. 2008. Sex Differences in Autoimmune Disease from a Pathological Perspective. The American Journal of Pathology, 173(3).

DOI: 10.2353/ajpath.2008.071008

Google Scholar

[8] Rezaei N, F.A Bonilla, K.E Sullivan, E. de Vries, Orange, J. S. 2008. An Introduction to Primary Immunodeficiency Diseases. 5 ed. Berlin, Springer-Verlag.

DOI: 10.1007/978-3-540-78936-9_1

Google Scholar

[9] Herrmann M, Schölmerich J, Straub RH. 2000. Stress and Rheumatic Diseases. Rheum Dis Clin North Am, 26: 737–763.

DOI: 10.1016/s0889-857x(05)70167-8

Google Scholar

[10] Eun Wha Choi. 2009. Adult Stem Cell Therapy for Autoimmune Disease. Int J Stem Cells, 2(2): 122–128.

DOI: 10.15283/ijsc.2009.2.2.122

Google Scholar

[11] Fedik A. Rantam, Ferdiansyah, Purwati. 2015. Stem Cell: Mesenchymal Hematopoetik, dan Model Aplikasi, Edisi Kedua. Surabaya: Airlangga University Press.

Google Scholar

[12] Tyndall A. 2009. Cellular Therapy of Systemic Lupus Erythematosus. Lupus, 18: 387–393.

DOI: 10.1177/0961203308100385

Google Scholar

[13] González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. 2009. Treatment of Experimental Arthritis by Inducing Immune Tolerance with Human Adipose-Derived Mesenchymal Stem Cells. Arthritis Rheum. 60(4): 1006-19.

DOI: 10.1002/art.24405

Google Scholar

[14] Purwati, Sony Wibisono, Ari Sutjahjo, Askandar T.J, Fedik A. Rantam. 2017. Adipose-Derived Mesenchymal Stem Cells for Treatment Tertiary Failure Diabetes Mellitus Type 2. Journal of Biomimetics, Biomaterials and Biomedical Engineering, 31: 91-95.

DOI: 10.4028/www.scientific.net/jbbbe.31.91

Google Scholar

[15] Adachi Y, Inaba M, Amoh Y, Yoshifusa H, Nakamura Y. 1995. Effect of Bone Marrow Transplantation on Antiphospholipid Antibody Syndrome in Murine Lupus Mice. Immunobiology, 192: 218-230.

DOI: 10.1016/s0171-2985(11)80099-9

Google Scholar

[16] Lendeckel S, Jödicke A, Christophis P, Heidinger K, Wolff J, Fraser JK, Hedrick MH, Berthold L, Howaldt HP. 2004. Autologous Stem Cells (Adipose) and Fibrin Glue Used to Treat Widespr Ead Traumatic Calvarial Defects: Case Report. J Craniomaxillofac Surg, 32: 370-373.

DOI: 10.1016/j.jcms.2004.06.002

Google Scholar

[17] Lai M, De Stefano V, Landolfi R. 2014. Haemoglobin Levels in Autoimmune Haemolytic Anaemias at Diagnosis: Relationship with Immunoproteins on Red Blood Cells. Immunol Res, 60(1): 127-31.

DOI: 10.1007/s12026-014-8497-0

Google Scholar

[18] Rogers, Kara, ed. 2011. Leukocytosis Definition. Blood: Physiology and Circulation, Chicago: Britannica Educational Publishing, p.198.

Google Scholar

[19] Liu S, Ren J, Xia Q, Wu X, Han G, Ren H, Yan D, Wang G, Gu G, Li J. 2013. Preliminary Case-control Study to Evaluate Diagnostic Values of C-Reactive Protein and Erythrocyte Sedimentation Rate in Differentiating Active Crohn's Disease From Intestinal Lymphoma, Intestinal Tuberculosis and Behcet's Syndrome. The American Journal of the Medical Sciences, 346 (6): 467-72.

DOI: 10.1097/maj.0b013e3182959a18

Google Scholar

[20] McPherson RA, Pincus MR. 2007. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st. Philadelphia, Pa: WB Saunders, p.40–1.

Google Scholar

[21] Klippel JH, Stone JH, Crofford LJ, White PH. 2008. Primer on Rheumatic Diseases. Thirteenth. Chapter 2. Springer, pp.15-20.

Google Scholar

[22] Lahita RG, Weinstein A. 2007. Educational Review Manual in Rheumatology. 4th. Chapter 1. New York, NY: Castle Connolly Graduate Medical Publishing, Ltd, pp.1-42.

Google Scholar

[23] Christine Castro and Mark Gourley. 2010. Diagnostic Testing and Interpretation of Tests for Autoimmunity. J Allergy Clin Immunol, 125 (2 Suppl 2): S238–S247.

DOI: 10.1016/j.jaci.2009.09.041

Google Scholar